March 24, 2022 - CONSENT OF KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. - 20-F: Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) | CollPlant Biotechnologies Ltd. (CLGN)

Form: 20-F

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

March 24, 2022

Documents

Exhibit 15.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (Nos. 333-228054 and 333-238731) and on Form S-8 (Nos. 333-229163 and 333-248479) of CollPlant Biotechnologies Ltd. of our report dated April 1, 2020 relating to the financial statements, which appears in this Form 20-F.

 

 

Tel-Aviv, Israel /s/ Kesselman & Kesselman
March 24, 2022 Certified Public Accountants (Isr.)
  A member firm of PricewaterhouseCoopers International Limited